This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
The calprotectin biomarker test stands at the crossroads to help direct physicians and patients to appropriate focused care for gut and brain symptoms.
Dayan Goodenowe’s research focuses on using biomarkers like plasmalogens for early cancer detection.”
